Literature DB >> 5944275

Biochemical studies on human and rat breast tissues.

J A Smith, R J King, B F Meggitt, L N Allen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5944275      PMCID: PMC2008952          DOI: 10.1038/bjc.1966.41

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  ENZYME PATTERNS IN HUMAN TISSUES. I. METHODS FOR THE DETERMINATION OF GLYCOLYTIC ENZYMES.

Authors:  C E SHONK; G E BOXER
Journal:  Cancer Res       Date:  1964-05       Impact factor: 12.701

2.  COMPARATIVE BIOCHEMISTRY OF HEPATOMAS. III. CARBOHYDRATE ENZYMES IN LIVER TUMORS OF DIFFERENT GROWTH RATES.

Authors:  G WEBER; H P MORRIS
Journal:  Cancer Res       Date:  1963-08       Impact factor: 12.701

3.  ENZYME PATTERNS IN HUMAN TISSUES. 3. GLYCOLYTIC ENZYMES IN NORMAL AND MALIGNANT TISSUES OF THE COLON AND RECTUM.

Authors:  C E SHONK; R N ARISON; B J KOVEN; H MAJIMA; G E BOXER
Journal:  Cancer Res       Date:  1965-02       Impact factor: 12.701

4.  PATTERNS OF GLYCOLYTIC ENZYMES IN RAT LIVER AND HEPATOMA.

Authors:  C E SHONK; H P MORRIS; G E BOXER
Journal:  Cancer Res       Date:  1965-06       Impact factor: 12.701

5.  The histology of induced mammary tumours in rats.

Authors:  S YOUNG; D M COWAN; L E SUTHERLAND
Journal:  J Pathol Bacteriol       Date:  1963-04

6.  Steroid influences on respiration, glycolysis, and levels of pyridine nucleotide-linked dehydrogenases of experimental mammary cancers.

Authors:  E D REES; C HUGGINS
Journal:  Cancer Res       Date:  1960-07       Impact factor: 12.701

7.  Serum phosphohexose isomerase in cancer. I. Method of determination and establishment of range of normal values.

Authors:  O BODANSKY
Journal:  Cancer       Date:  1954-11       Impact factor: 6.860

8.  beta-Glucuronidase and related enzymes.

Authors:  G A LEVVY
Journal:  Br Med Bull       Date:  1953       Impact factor: 4.291

Review 9.  Hormone assays in human breast cancer.

Authors:  R D Bulbrook
Journal:  Vitam Horm       Date:  1965       Impact factor: 3.421

10.  Role of histones and other proteins in gene control.

Authors:  J A Butler
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

View more
  8 in total

1.  The histochemistry of isocitric and oestradiol-17 beta dehydrogenases in the endometrium of postmenopausal women treated with oestrogens and progestogens.

Authors:  G Lane
Journal:  Histochem J       Date:  1990-01

2.  Cytochemical investigation of glucose-6-phosphate dehydrogenase activity in rat mammary tissue.

Authors:  P P Smyth; E T Barron; I Tobbia; N J O'Higgins
Journal:  Br J Exp Pathol       Date:  1987-02

3.  Enzyme activity, acidic nuclear proteins, and prognosis in human breast cancer.

Authors:  J A Smith; R J King; B F Meggitt; L N Allen
Journal:  Br Med J       Date:  1970-06-20

4.  The properties of a nuclear acidic protein fraction that binds [6,7-3H]oestradiol-17beta.

Authors:  R J King; J Gordon; A W Steggles
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

5.  Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.

Authors:  G Lane; N C Siddle; T A Ryder; J Pryse-Davies; R J King; M I Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

6.  Effect of hormone manipulation on oxidation, reduction and sulphurylation of dehydroepiandrosterone and oestrone in DMBA-induced rat mammary tumours.

Authors:  K Li; D P Chandra; T Pewnim; T Foo; J B Adams
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

7.  Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast.

Authors:  A Szutowicz; J Kwiatkowski; S Angielski
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

8.  Nuclear proteins and their metabolism in hormone responsive and unresponsive BR6 mouse mammary tumours.

Authors:  J A Smith; R J King
Journal:  Br J Cancer       Date:  1970-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.